Fulgent Genetics Inc. (NASDAQ:FLGT) Q4 2023 Earnings Conference Call February 28, 2024 8:30 AM ET
Company Participants
Ming Hsieh - Chairman, Chief Executive Officer
Paul Kim - Chief Financial Officer
Brandon Perthuis - Chief Commercial Officer
Melanie Solomon - Investor Relations
Conference Call Participants
David Westenberg - Piper Sandler
Andrew Cooper - Raymond James
Liu Li - UBS
Operator
Greetings and welcome to the Fulgent Genetics fourth quarter and full year 2023 conference call and webcast.
At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require Operator assistance during the conference, please press star, zero on your telephone keypad. As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Melanie Solomon, Investor Relations for Fulgent Genetics. Please go ahead.
Melanie Solomon
Thank you. Good morning and welcome to the Fulgent fourth quarter and full year 2023 financial results conference call. On the call are Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer.
The company’s press release discussing the financial results is available on the Investor Relations section of the company’s website, www.fulgentgenetics.com. A replay of this call will be available shortly after the call concludes on the Investor Relations section of the company’s website.
Management’s prepared remarks and answers to your questions on today’s call contain forward-looking statements. These forward-looking statements represent management’s estimates based on current views and assumptions which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties and changes in circumstances that may cause actual results to differ from those described in the forward-looking statements. The company assumes no obligation to update any of the forward-looking statements it may make today to reflect actual results or changes in expectations. Listeners should not rely on any forward-looking statements as predictions of future events and should listen to management’s remarks today with the understanding that actual events, including the company’s actual future results, may be materially different in what is prescribed in or implied by these forward-looking statements.
Please review the more detailed discussions related to these forward-looking statements, including the discussions of some of the risk factors that may cause results to differ from those described in the forward-looking statements contained in the company’s filings with the Securities and Exchange Commission, including the previously filed 10-K for the year ended December 31, 2022 and subsequently filed reports, which are available on the company’s Investor Relations website.